Pharma Dynamics got granted the exclusive marketing and sales rights of Rosamed Group, Teheran, Iran. Under Rosamed the states production of Morphine and its derivates of the Iranian manufacturers is united, controlled by the INCB (International Narcotic Consumption Board) in Vienna, Austria.


Pharma Dynamics GmbH opened its affiliate in Shanghai, PR China to tighten relations with API manufacturers of Anticancer drugs.


Pharma Dynamics GmbH entered into a joint venture with Chemigran Industrial (S) Pte Ltd., Singapore for the search of new chemical entities for cancer treatment.


Pharma Dynamics GmbH engaged in compounding of cytostatic preparations with Oncosachs, Germany and ZytoService, Germany.


Pharma Dynamics GmbH takes part in a merger and acquisitions team of ratiopharm, Germany to divest the oncology business of ribosepharm to Hikma Pharmaceuticals Plc, Jordan.


Pharma Dynamics GmbH supports Dr. Reddy’s, Hyderabad, India acquired business of betapharm, Augsburg, Germany and made a proposal of the new concept Oncology Europe.


Together with LAT GmbH, Germany Pharma Dynamics GmbH exploits the possibilities of dry extract of wolf berry, a traditional Chinese medicine, to cure solid tumors.